DnB Asset Management AS Increases Stock Holdings in Humana Inc. (NYSE:HUM)

DnB Asset Management AS increased its position in shares of Humana Inc. (NYSE:HUM) by 6.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 168,019 shares of the insurance provider’s stock after acquiring an additional 10,179 shares during the period. DnB Asset Management AS owned approximately 0.13% of Humana worth $75,126,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of HUM. Sunbelt Securities Inc. bought a new position in shares of Humana in the first quarter worth approximately $28,000. MV Capital Management Inc. increased its holdings in shares of Humana by 40.8% in the 1st quarter. MV Capital Management Inc. now owns 69 shares of the insurance provider’s stock worth $33,000 after buying an additional 20 shares during the last quarter. Householder Group Estate & Retirement Specialist LLC purchased a new stake in shares of Humana during the 1st quarter valued at $39,000. Delta Asset Management LLC TN bought a new stake in shares of Humana during the 4th quarter worth $46,000. Finally, Key Financial Inc grew its position in Humana by 130.4% in the first quarter. Key Financial Inc now owns 106 shares of the insurance provider’s stock worth $52,000 after acquiring an additional 60 shares in the last quarter. 91.86% of the stock is currently owned by hedge funds and other institutional investors.

Humana Trading Down 0.6 %

Shares of NYSE HUM traded down $3.04 during midday trading on Thursday, hitting $469.46. 243,521 shares of the company traded hands, compared to its average volume of 1,160,767. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.37 and a current ratio of 1.37. Humana Inc. has a 12-month low of $423.29 and a 12-month high of $571.30. The stock has a 50-day moving average price of $466.84 and a 200 day moving average price of $487.22. The firm has a market cap of $58.17 billion, a P/E ratio of 17.63, a P/E/G ratio of 1.22 and a beta of 0.66.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 2nd. The insurance provider reported $8.94 earnings per share for the quarter, topping analysts’ consensus estimates of $8.88 by $0.06. The firm had revenue of $26.75 billion for the quarter, compared to the consensus estimate of $25.83 billion. Humana had a return on equity of 20.70% and a net margin of 3.42%. The business’s revenue for the quarter was up 13.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $8.67 EPS. As a group, analysts expect that Humana Inc. will post 28.25 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio (DPR) is presently 13.21%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HUM. Sanford C. Bernstein lifted their price target on Humana from $568.00 to $599.00 and gave the stock a “market perform” rating in a research note on Tuesday, August 8th. Wells Fargo & Company dropped their target price on Humana from $610.00 to $541.00 in a research report on Thursday, July 13th. TD Cowen lowered their price objective on shares of Humana from $616.00 to $613.00 and set an “outperform” rating for the company in a report on Tuesday, August 15th. Barclays cut their price objective on shares of Humana from $620.00 to $585.00 in a research note on Monday, June 19th. Finally, Truist Financial lifted their target price on shares of Humana from $530.00 to $550.00 and gave the stock a “hold” rating in a research report on Thursday, August 3rd. Four investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $592.30.

Humana Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.